US Drug Recall Register
Class III · Low risk Terminated Initiated Nov 19, 2021 (5 years ago)

Tydemy (drospirenone, ethinyl estradiol & levomefolate calcium tablets, 3 mg/0.03…

Class III — Low risk. Unlikely to cause harm, but violates FDA regulations.

Why it was recalled

Subpotent Drug

What was recalled

Tydemy (drospirenone, ethinyl estradiol & levomefolate calcium tablets, 3 mg/0.03 mg/0.451 mg and levomefolate calcium tablets, 0.451 mg), packaged in cartons containing 3 wallets of 28 Tablets each, Rx Only, Distributed by: Lupin Pharmaceuticals, Inc., Baltimore, Maryland 21202, United Stated, Manufactured by: Lupin Limited, Pithampur, (M.P.) - 454775, India, 244896, The individual wallet NDC 68180-904-11 and the carton NDC 68180-904-13.

Recalling firm
Lupin Pharmaceuticals Inc.
NDC code
68180-904-11
Origin
MD, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0264-2022

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Estradiol recalls

See all